Directory
>
Megan Knight
Megan Knight
Vice President, Head of Investor Relations | Longboard Pharmaceuticals
San Diego, California, United States
Megan Knight
Summary
Megan Knight is a seasoned investor relations professional with a strong background in the biotechnology and pharmaceutical sectors. With over 15 years of experience, she has successfully led investor relations at Longboard Pharmaceuticals and previously at Arena Pharmaceuticals. Megan is known for her strategic approach, combining analytical skills with effective communication to enhance corporate reputation and engage stakeholders. Her expertise spans across corporate branding, crisis communications, and financial modeling, making her a valuable asset in the life sciences industry. She has been recognized with the Niri Individual Chapter Leadership Award for her contributions to the field. Megan holds a B.A. in Communications from San Diego State University, showcasing her strong foundational skills in corporate communications. She is passionate about fostering investor relationships and driving business strategies that promote company growth and transparency.
Megan Knight
Work Experience
Vice President, Head of Investor Relations at
Longboard Pharmaceuticals
February 2024 - Present
Head of Investor Relations at
Longboard Pharmaceuticals
January 2021 - February 2024
Director, Investor Relations at
Arena Pharmaceuticals, Inc.
March 2020 - January 2021
Associate Director, Investor Relations at
Arena Pharmaceuticals, Inc.
March 2019 - March 2020
Senior Manager, Investor Relations at
Arena Pharmaceuticals, Inc.
September 2016 - March 2019
Senior Analyst, Investor Relations and Corporate Communications at
Senomyx
March 2014 - September 2016
Analyst, Investor Relations & Corporate Communications at
Senomyx
January 2013 - January 2016
Associate, Investor Relations and Corporate Communications at
Senomyx
January 2007 - January 2012
Administration & Legal Clerk - Internship at
Senomyx
January 2006 - January 2007
Megan Knight
Education
San Diego State University, B.A.
January 2001 - January 2005
Frequently Asked Questions about Megan Knight
What is Megan Knight email address?
Megan Knight's primary email address is *****@longboardpharma.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Megan Knight work for?
Megan Knight is a Vice President, Head of Investor Relations at Longboard Pharmaceuticals, a company specializing in Commercial physical research.
Where Megan Knight graduated from?
Megan Knight holds a degree in Communications from San Diego State University.
How can I directly contact Megan Knight?
To contact Megan Knight directly, you can use the email address *****@longboardpharma.com. Complete contact information is available upon registration with Muraena.
Who is Megan Knight?
Megan Knight is a seasoned investor relations professional with a strong background in the biotechnology and pharmaceutical sectors. With over 15 years of experience, she has successfully led investor relations at Longboard Pharmaceuticals and previously at Arena Pharmaceuticals. Megan is known for her strategic approach, combining analytical skills with effective communication to enhance corporate reputation and engage stakeholders. Her expertise spans across corporate branding, crisis communications, and financial modeling, making her a valuable asset in the life sciences industry. She has been recognized with the Niri Individual Chapter Leadership Award for her contributions to the field. Megan holds a B.A. in Communications from San Diego State University, showcasing her strong foundational skills in corporate communications. She is passionate about fostering investor relationships and driving business strategies that promote company growth and transparency.
Megan`s contact details
*****@longboardpharma.com
************@senomyx.com
Colleagues
Vice President - Head of Business Development
Vice President, Nonclinical Research and Development
Chief Medical Officer
Vice President, Medical Affairs
Vice President Commercial Strategy
President and CEO
Executive Vice President, Head of Operations
Vice President, Chemistry and CMC
Director and Audit Committee Chair
Vice President & General Manager Europe / International